Brain Metastasis

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
Heinz Läubli, Jürgen Hench, Michal Stanczak, Ingmar Heijnen, Alexandros Papachristofilou, Stephan Frank, Alfred Zippelius, Frank Stenner-Liewen

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 46; DOI: 10.1186/s40425-017-0249-y
Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine
Alex Karlsson-Parra, Anna Laurell, Maria Lönnemark, Einar Brekkan, AnnaCarin Wallgren, Anders Magnusson

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P438; DOI: 10.1186/2051-1426-3-S2-P438
Development of HER2-specific chimeric antigen receptor T cells for the treatment of breast-to-brain metastasis
Saul Priceman, Brenda Aguilar, Renate Starr, Dileshni Tilakawardane, Anthony Park, Ethan Gerdts, Wen-Chung Chang, Sarah Wright, Stephen J Forman, Christine E Brown

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P121; DOI: 10.1186/2051-1426-3-S2-P121
Harnessing the potential of radiation treatment of brain metastases to improve melanoma immunotherapy
Corey D McNeilly, Lukas W Pfannenstiel, Chaomei Xiang, Jennifer Yu, Brian R Gastman

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P367; DOI: 10.1186/2051-1426-3-S2-P367
Feasibility of dc vaccine combined with low dose endoxan and high dose il-2 treatment associated with taurolidine for advanced, multi-resistant melanoma patients.
Gustavo A Moviglia, Ralf Kleef

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P209; DOI: 10.1186/2051-1426-3-S2-P209
Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma
Ashwin Chandar, Ann W Silk, Joseph I Clark, Gregory A Daniels, David F McDermott, Michael Morse, Michael KK Wong, Mark Stein, Janice Mehnert, Shabbar Danish, Sandra Aung, Howard L Kaufman

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P129; DOI: 10.1186/2051-1426-3-S2-P129
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)
Paolo Antonio Ascierto, E Simeone, V Chiarion Sileni, P Queirolo, M Del Vecchio, L Di Guardo, M Guidoboni, P Marchetti, GC Antonini Cappellini, PF Ferrucci, F Cognetti, MG Bernengo, M Guida, R Marconcini, M Mandalà, C Cimminiello, G Rinaldi, M Aglietta, L Calabrò, M Maio

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P69; DOI: 10.1186/2051-1426-1-S1-P69

Log in using your username and password

Main menu

Log in using your username and password

You are here

Brain Metastasis